Associated Papers
Association of immune relevant single nucleotide polymorphisms with ALK-positive anaplastic large cell lymphoma presentation and outcome: results of the immuno ALCL study.
Adriana P et al.
Journal of Translational Medicine, 2025
Proteogenomic Profiling of Treatment-Naïve Metastatic Malignant Melanoma.
Kuras M et al.
Cancers, 2025
The pharmacogenomic landscape in the Chinese: An analytics of pharmacogenetic variants in 206,640 individuals.
Wang LY et al.
Innovation (cambridge (mass.)), 2025
Annexin A1 and its receptor gene polymorphisms in systemic lupus erythematosus in the Tunisian population.
Dhaffouli F et al.
Clinical Rheumatology, 2022
A loss-of-function polymorphism in ATG16L1 compromises therapeutic outcome in head and neck carcinoma patients.
Le Naour J et al.
Oncoimmunology, 2022
A TLR3 Ligand Reestablishes Chemotherapeutic Responses in the Context of FPR1 Deficiency.
Le Naour J et al.
Cancer Discovery, 2021
No impact of cancer and plague-relevant FPR1 polymorphisms on COVID-19.
Petrazzuolo A et al.
Oncoimmunology, 2020
Pattern Recognition Receptor Polymorphisms as Predictors of Oxaliplatin Benefit in Colorectal Cancer.
Gray V et al.
Journal of the National Cancer Institute, 2019
Formyl Peptide Receptor Polymorphisms: 27 Most Possible Ways for Phagocyte Dysfunction.
Skvortsov SS et al.
Biochemistry. Biokhimiia, 2017
Mutations modifying sporadic Alzheimer's disease age of onset.
Vélez JI et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics, 2016
FPR1 interacts with CFH, HTRA1 and smoking in exudative age-related macular degeneration and polypoidal choroidal vasculopathy.
Liang XY et al.
Eye (london, England), 2014
V101L of human formyl peptide receptor 1 (FPR1) increases receptor affinity and augments the antagonism mediated by cyclosporins.
Zhou C et al.
The Biochemical Journal, 2013
Functional nsSNPs from carcinogenesis-related genes expressed in breast tissue: potential breast cancer risk alleles and their distribution across human populations.
Savas S et al.
Human Genomics, 2006
Evaluation of human leukocyte N-formylpeptide receptor (FPR1) SNPs in aggressive periodontitis patients.
Zhang Y et al.
Genes and Immunity, 2003
Contrasting evolution of the human leukocyte N-formylpeptide receptor subtypes FPR and FPRL1R.
Sahagun-Ruiz A et al.
Genes and Immunity, 2001